Expression of human β‐defensins‐1 and ‐2 peptides in unresolved chronic periodontitis
Authors:
- 25 March 2004
- journal article
- Published by Wiley in Journal of Periodontal Research
- Vol. 39 (4) , 221-227
Abstract
Background: Human β‐defensins (hBDs) are antimicrobial peptides which contribute to host innate immunity by disrupting the membrane integrity of a broad spectrum of microorganisms.Objectives: This study aimed to determine the expression profiles of hBD‐1 and ‐2 peptides in gingiva and to assess the possible relations of these antimicrobial peptides with periodontal health and disease.Methods: Seven periodontally healthy subjects and 22 patients with unresolved chronic periodontitis were recruited and the gingival biopsies collected consisted of healthy tissues from the healthy subjects (HT‐C); periodontal pocket tissues (PoT) and inflamed connective tissues (ICT) from the base of pocket, i.e. granulation tissues, as well as clinically healthy tissues (HT‐P) from the adjacent clinically healthy sites from the patients. The expression of hBD‐1 and ‐2 peptides was detected by immunohistochemistry and quantitatively analyzed with a computerized image processing system.Results: Both hBD‐1 and ‐2 peptides were detected in all periodontally healthy subjects, while hBD‐1 was detected in all patients and hBD‐2 was found in most of the patients. Their expression was mainly confined to the granular and spinous layers of gingival epithelium, in which hBD‐1 was detected in both intercellular spaces and cytoplasm, whereas hBD‐2 was mainly observed in the cytoplasm. HT‐C expressed significantly higher levels of hBD‐2 than HT‐P (p < 0.05). Within the patients, both defensins were up‐regulated significantly in PoT as compared with the adjacent HT‐P (p < 0.05).Conclusions: The present study showed that hBD‐1 and ‐2 were frequently expressed in the granular and spinous layers of gingival epithelia and their expression may be associated with periodontal health and disease.Keywords
This publication has 34 references indexed in Scilit:
- Relationship of changes in interleukin‐8 levels and granulocyte elastase activity in gingival crevicular fluid to subgingival periodontopathogens followingnon‐surgical periodontal therapy in subjects with chronic periodontitisJournal of Clinical Periodontology, 2002
- The novel human beta‐defensin‐3 is widely expressed in oral tissuesEuropean Journal of Oral Sciences, 2002
- Human β Defensin-1 and -2 Expression in Human Pilosebaceous Units: Upregulation in Acne Vulgaris LesionsJournal of Investigative Dermatology, 2001
- Isolation and Characterization of Human μ-Defensin-3, a Novel Human Inducible Peptide AntibioticJournal of Biological Chemistry, 2001
- Inducible Expression of Human β-Defensin 2 byFusobacterium nucleatumin Oral Epithelial Cells: Multiple Signaling Pathways and Role of Commensal Bacteria in Innate Immunity and the Epithelial BarrierInfection and Immunity, 2000
- Transcriptional Regulation of β-Defensin Gene Expression in Tracheal Epithelial CellsInfection and Immunity, 2000
- Human beta-defensin-1: an antimicrobial peptide of urogenital tissues.Journal of Clinical Investigation, 1998
- Widespread expression of beta‐defensin hBD‐1 in human secretory glands and epithelial cellsFEBS Letters, 1996
- hBD‐1: a novel β‐defensin from human plasmaFEBS Letters, 1995
- Defensin‐6 mRNA in human Paneth cells: implications for antimicrobia peptides in host defense of the human bowelFEBS Letters, 1993